XBiotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of XBiotech generated cash of -$18,725,000, which is less than the previous year. Cash used in financing activities reached the amount of -$9,000 last year. Net change in cash is therefore $42,717,000.
Cash Flow
| 2014 | -11.7M | -1.39M | 63.2M |
|---|---|---|---|
| 2015 | -33.30M | -10.39M | 77.47M |
| 2016 | -46.01M | -13.91M | 2.94M |
| 2017 | -33.64M | -1.40M | 33.32M |
| 2018 | -16.53M | -122K | 201K |
| 2019 | -18.27M | 674.79M | 42.09M |
| 2020 | -65.14M | -3.72M | -409.72M |
| 2021 | 69.44M | -3.52M | -67.00M |
| 2022 | -14.82M | -63.89M | 0 |
| 2023 | -18.72M | 61.49M | -9K |
XBIT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 157.30M | 236.98M | 237.36M | 714.59M | 15.82M | 31.76M | 34.32M | 91.05M | 57.32M | 7.24M |
Operating activities | ||||||||||
Net income | -24.55M | -32.9M | -17.41M | -11.22M | 668.62M | -21.13M | -33.15M | -52.76M | -37.48M | -21.72M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.74M | 2.61M | 2.64M | 2.23M | 2.36M | 2.43M | 1.48M | 698K | 699K | 664K |
Stock-based compensation expense | 3.26M | 5.06M | 4.46M | 12.58M | 3.35M | 0 | 1.75M | 5.57M | 4.40M | 7.02M |
| Deferred income tax benefit | 3.26M | 5.06M | 4.46M | 12.58M | 3.35M | 0 | 1.75M | 5.57M | 4.40M | 7.02M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 829K | 8.55M | 4.11M | -4.11M | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | -8.55M | -2.49M | -57.53M | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 91K | 357K | -514K | -334K | 496K | -78K | -2.7M | -981K | 840K | 1.06M |
Cash generated by operating activities | -18.72M | -14.82M | 69.44M | -65.14M | -18.27M | -16.53M | -33.64M | -46.01M | -33.30M | -11.7M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -63.30M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -362K | -585K | -3.52M | -3.72M | -204K | -122K | -1.40M | -13.91M | -10.39M | -1.39M |
Acquisitions Net | 0 | 0 | 0 | 0 | 675M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 61.49M | -63.89M | -3.52M | -3.72M | 674.79M | -122K | -1.40M | -13.91M | -10.39M | -1.39M |
Financing activities | ||||||||||
Common Stock Issued | 5K | 0 | -420M | -420M | 38.06M | 201K | 32.62M | 1.80M | 75.71M | 0 |
Payments for dividends | 0 | 0 | -75.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -420M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -9K | 0 | -67.00M | -409.72M | 42.09M | 201K | 33.32M | 2.94M | 77.47M | 63.2M |
Net Change In Cash | 42.71M | -79.67M | -383K | -477.22M | 698.77M | -15.94M | -2.55M | -56.72M | 33.72M | 50.08M |
Cash at end of period | 200.02M | 157.30M | 236.98M | 237.36M | 714.59M | 15.82M | 31.76M | 34.32M | 91.05M | 57.32M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |